Cholecalciferol Supplementation Does Not Affect the Risk of HIV Progression, Viral Suppression, Comorbidities, Weight Loss, and Depression among Tanzanian Adults Initiating Antiretroviral Therapy: Secondary Outcomes of a Randomized Trial.
Alfa MuhihiWafaie W FawziSaid AboudTumaini J NaguNzovu UlengaMolin WangFerdinand MugusiChristopher Robert SudfeldPublished in: The Journal of nutrition (2022)
Vitamin D supplementation did not affect the risk of HIV progression, viral suppression, common morbidities, weight-related indicators, or depression among adults initiating ART in Tanzania.This trial was registered at clinicaltrials.gov as NCT01798680.
Keyphrases
- antiretroviral therapy
- hiv infected
- weight loss
- hiv positive
- human immunodeficiency virus
- hiv aids
- hiv infected patients
- sars cov
- depressive symptoms
- bariatric surgery
- sleep quality
- body mass index
- roux en y gastric bypass
- study protocol
- gastric bypass
- clinical trial
- hiv testing
- hepatitis c virus
- physical activity
- men who have sex with men
- randomized controlled trial
- phase iii
- glycemic control
- south africa
- adipose tissue
- insulin resistance
- obese patients